273 related articles for article (PubMed ID: 7911441)
1. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
Harris AG
Gut; 1994; 35(3 Suppl):S1-4. PubMed ID: 7911441
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
Gyr KE; Meier R
Digestion; 1993; 54 Suppl 1():14-9. PubMed ID: 8103010
[TBL] [Abstract][Full Text] [Related]
3. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I
Digestion; 1987; 36(2):108-24. PubMed ID: 2883060
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
Gyr KE; Meier R
Metabolism; 1992 Sep; 41(9 Suppl 2):17-21. PubMed ID: 1518430
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours.
Chanson P; Timsit J; Harris AG
Clin Pharmacokinet; 1993 Nov; 25(5):375-91. PubMed ID: 8287633
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue.
Whitehouse I; Beglinger C; Rüttimann G; Gyr K
Gut; 1986 Feb; 27(2):141-6. PubMed ID: 2868973
[TBL] [Abstract][Full Text] [Related]
7. Octreotide, a new somatostatin analogue.
Katz MD; Erstad BL
Clin Pharm; 1989 Apr; 8(4):255-73. PubMed ID: 2653711
[TBL] [Abstract][Full Text] [Related]
8. [Octreotide, analog of somatostatin. Pharmacological properties and therapeutic applications in pituitary endocrine tumors].
Chanson P; Timsit J; Harris AG
Presse Med; 1993 Dec; 22(40):2009-16. PubMed ID: 7907419
[TBL] [Abstract][Full Text] [Related]
9. Human pharmacological effects of SMS 201-995 on gastric secretion.
Gyr KE; Whitehouse I; Beglinger C; Köhler E; Dettwiler S; Fried M
Scand J Gastroenterol Suppl; 1986; 119():96-102. PubMed ID: 2876511
[TBL] [Abstract][Full Text] [Related]
10. Rat pancreas after long-term treatment with the somatostatin analogue octreotide.
von Schönfeld J; Meisse F; Müller MK
Exp Physiol; 1995 Nov; 80(6):1031-8. PubMed ID: 8962703
[TBL] [Abstract][Full Text] [Related]
11. The effect of somatostatin analogue octreotide on amylase secretion from mouse pancreatic acini.
Ishiguro H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Sobajima H; Nakae Y; Tanikawa M
Digestion; 1993; 54(4):207-12. PubMed ID: 7694882
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin analogues and exocrine pancreatic secretion.
Gullo L
Digestion; 1996; 57 Suppl 1():93. PubMed ID: 8813482
[TBL] [Abstract][Full Text] [Related]
13. Debut of a somatostatin analog: octreotide in review.
Zindel LR
Conn Med; 1989 Dec; 53(12):741-4. PubMed ID: 2558839
[TBL] [Abstract][Full Text] [Related]
14. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.
Battershill PE; Clissold SP
Drugs; 1989 Nov; 38(5):658-702. PubMed ID: 2689136
[TBL] [Abstract][Full Text] [Related]
15. Octreotide: a clinical update.
Meier RF; Reichert MM
Saudi J Gastroenterol; 1998 Sep; 4(3):147-55. PubMed ID: 19864763
[TBL] [Abstract][Full Text] [Related]
16. Effect of octreotide, a long-acting somatostatin analogue, on plasma amino acid uptake by the pancreas.
Gullo L; Pezzilli R; Ancona D; Labate AM; Barbara L
Pancreas; 1991 Nov; 6(6):668-72. PubMed ID: 1780327
[TBL] [Abstract][Full Text] [Related]
17. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans.
Creutzfeldt W; Lembcke B; Fölsch UR; Schleser S; Koop I
Am J Med; 1987 May; 82(5B):49-54. PubMed ID: 2884879
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous observation of endocrine and exocrine functions of the pancreas responding to somatostatin in man.
Emoto T; Miyata M; Izukura M; Yumiba T; Mizutani S; Sakamoto T; Matsuda H
Regul Pept; 1997 Jan; 68(1):1-8. PubMed ID: 9094748
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
Jenkins SA; Nott DM; Baxter JN
HPB Surg; 1998; 11(1):13-21. PubMed ID: 9830576
[TBL] [Abstract][Full Text] [Related]
20. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.
Misumi A; Shiratori K; Lee KY; Barkin JS; Chey WY
Surgery; 1988 Apr; 103(4):450-5. PubMed ID: 2895501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
